Platelet activating factor

Platelet activating factor is a lipid of Glycerophospholipids (GP) class. Platelet activating factor is associated with abnormalities such as Atherosclerosis, Acute cholecystitis without calculus, Cholecystitis, Colitis and Cholecystitis, Acute. The involved functions are known as Cell Survival, Metabolic Inhibition, lipid oxidation, Apoptosis and Oxidation. Platelet activating factor often locates in soluble, Cellular Membrane, Smooth muscle (tissue), Intima and Tissue specimen. The associated genes with Platelet activating factor are apolipoprotein A-I Milano, Homologous Gene, TSPO gene, HBEGF gene and SLC33A1 gene. The related lipids are Hydroxycholesterols, Liposomes, 25-hydroxycholesterol, Lysophosphatidylcholines and Lipopolysaccharides. The related experimental models are Knock-out, Mouse Model and Transgenic Model.

Cross Reference

Introduction

To understand associated biological information of Platelet activating factor, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Platelet activating factor?

Platelet activating factor is suspected in Ischemia, Pleurisy, Atherosclerosis, Inflammatory disorder, Retinal Diseases, Diabetes and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Platelet activating factor

MeSH term MeSH ID Detail
Cholestasis D002779 23 associated lipids
Fibrosis D005355 23 associated lipids
Anemia, Sickle Cell D000755 34 associated lipids
Multiple Sclerosis D009103 13 associated lipids
Glomerulonephritis D005921 35 associated lipids
Nervous System Diseases D009422 37 associated lipids
Psoriasis D011565 47 associated lipids
Brain Edema D001929 20 associated lipids
Leukopenia D007970 9 associated lipids
Pseudomonas Infections D011552 25 associated lipids
Staphylococcal Skin Infections D013207 9 associated lipids
Burns, Inhalation D002059 4 associated lipids
Gram-Negative Bacterial Infections D016905 16 associated lipids
Fetal Weight D020567 12 associated lipids
Infarction, Middle Cerebral Artery D020244 35 associated lipids
Stroke D020521 32 associated lipids
Hyperlipoproteinemia Type II D006938 22 associated lipids
Brain Ischemia D002545 89 associated lipids
Ischemia D007511 18 associated lipids
Colonic Diseases D003108 5 associated lipids
Per page 10 20 50 100 | Total 288

PubChem Associated disorders and diseases

What pathways are associated with Platelet activating factor

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Platelet activating factor?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Platelet activating factor?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Platelet activating factor?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with Platelet activating factor?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Platelet activating factor?

Knock-out

Knock-out are used in the study 'A cardioprotective role for platelet-activating factor through NOS-dependent S-nitrosylation.' (Leary PJ et al., 2008).

Mouse Model

Mouse Model are used in the study 'A regulatory role of LPCAT1 in the synthesis of inflammatory lipids, PAF and LPC, in the retina of diabetic mice.' (Cheng L et al., 2009).

Transgenic Model

Transgenic Model are used in the study 'Heterogeneity in the sn-1 carbon chain of platelet-activating factor glycerophospholipids determines pro- or anti-apoptotic signaling in primary neurons.' (Ryan SD et al., 2008).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Platelet activating factor

Download all related citations
Per page 10 20 50 100 | Total 8526
Authors Title Published Journal PubMed Link
Lo CJ et al. Endotoxin-induced macrophage gene expression depends on platelet-activating factor. 1997 Arch Surg pmid:9403541
Uozumi N et al. Role of cytosolic phospholipase A2 in allergic response and parturition. 1997 Nature pmid:9403692
Soubeyrand S et al. Phospholipase A2 from bovine seminal plasma is a platelet-activating factor acetylhydrolase. 1998 Biochem. J. pmid:9405273
Coffer PJ et al. Comparison of the roles of mitogen-activated protein kinase kinase and phosphatidylinositol 3-kinase signal transduction in neutrophil effector function. 1998 Biochem. J. pmid:9405284
Tabuchi S et al. Lipid mediators modulate NMDA receptor currents in a Xenopus oocyte expression system. 1997 Neurosci. Lett. pmid:9406868
Adachi T et al. PAF analogues capable of inhibiting PAF acetylhydrolase activity suppress migration of isolated rat cerebellar granule cells. 1997 Neurosci. Lett. pmid:9406887
Zinchenko VP et al. [Effect of structural analogs of platelet activating factor on the intracellular signal transduction in murine peritoneal neutrophils and macrophages of P388D1 line]. 1997 Sep-Oct Biofizika pmid:9410037
Camici M et al. [Platelet activating factor (PAF) and kidney failure progression]. 1997 Minerva Med. pmid:9411309
Kertscher HP [PAF-antagonists with lipid structure. 6. Alkylpropandiol lipids with acyl- and ether- structures at the C-3 position and heterocyclic head groups; synthesis, characterization and structure-activity relationship]. 1997 Pharmazie pmid:9411454
Bix GJ and Clark GD Platelet-activating factor receptor stimulation disrupts neuronal migration In vitro. 1998 J. Neurosci. pmid:9412509
Zimmerman GA et al. Adhesion and signaling in vascular cell-cell interactions. 1997 J. Clin. Invest. pmid:9413392
Sozzani S et al. Human monocyte-derived and CD34+ cell-derived dendritic cells express functional receptors for platelet activating factor. 1997 FEBS Lett. pmid:9414103
Manabe H et al. KF19514, a phosphodieterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pigs. 1997 Int. Arch. Allergy Immunol. pmid:9414145
Maeda T et al. Hemodynamic depression and microthrombosis in the peripheral areas of cortical contusion in the rat: role of platelet activating factor. 1997 Acta Neurochir. Suppl. pmid:9416292
Prescott SM Inflammatory actions of platelet-activating factor: control by PAF acetylhydrolase. 1997 Sep-Oct J Investig Allergol Clin Immunol pmid:9416565
Mugnai S et al. Influence of interleukin 1alpha on superoxide anion, platelet activating factor release and phospholipase A2 activity of naive and sensitized guinea-pig alveolar macrophages. 1997 Br. J. Pharmacol. pmid:9421281
Shamsuddin M et al. Regulation of leukotriene and platelet-activating factor synthesis in human alveolar macrophages. 1997 J. Lab. Clin. Med. pmid:9422335
Matheson MJ et al. Role of platelet activating factor, leukotrienes and polymorphs in the FMLP induced increase in microvascular leakage in rabbit trachea. 1997 Respirology pmid:9424405
Hichami A et al. Modulation of platelet-activating-factor production by incorporation of naturally occurring 1-O-alkylglycerols in phospholipids of human leukemic monocyte-like THP-1 cells. 1997 Eur. J. Biochem. pmid:9428670
Igarashi Y [Physiology of sphingosine 1-phosphate: regulation of cell motility and platelet function]. 1997 Seikagaku pmid:9431007
Shindo K et al. Inhibitory effect of azelastine hydrochloride on synthesis and release of platelet activating factor from human alveolar macrophages. 1997 Prostaglandins Leukot. Essent. Fatty Acids pmid:9431823
Stack WA and Hawkey CJ Specific mediator-directed therapy for gastrointestinal diseases. 1997 Eur J Gastroenterol Hepatol pmid:9431894
Bennett SA and Birnboim HC Receptor-mediated and protein kinase-dependent growth enhancement of primary human fibroblasts by platelet activating factor. 1997 Mol. Carcinog. pmid:9433481
Dupuis F et al. Production, metabolism and effect of platelet-activating factor on the growth of the human K562 erythroid cell line. 1997 Biochim. Biophys. Acta pmid:9434130
Li CL and Wong YY The bioavailability of ginkgolides in Ginkgo biloba extracts. 1997 Planta Med. pmid:9434615
Albert DH et al. The role of platelet-activating factor (PAF) and the efficacy of ABT-491, a highly potent and selective PAF antagonist, in experimental allergic rhinitis. 1998 J. Pharmacol. Exp. Ther. pmid:9435164
Gamaley IA et al. Superoxide release is involved in membrane potential changes in mouse peritoneal macrophages. 1998 Free Radic. Biol. Med. pmid:9436627
Tsoukatos DC et al. Copper-catalyzed oxidation mediates PAF formation in human LDL subspecies. Protective role of PAF:acetylhydrolase in dense LDL. 1997 Arterioscler. Thromb. Vasc. Biol. pmid:9437199
Curtin ML et al. Discovery and evaluation of a series of 3-acylindole imidazopyridine platelet-activating factor antagonists. 1998 J. Med. Chem. pmid:9438024
De Matos IM et al. Lung oedema induced by Tityus serrulatus scorpion venom in the rat. 1997 Comp. Biochem. Physiol. C, Pharmacol. Toxicol. Endocrinol. pmid:9440240
Kokura S et al. Effects of rebamipide, a novel anti-ulcer agent, on gastric mucosal injury induced by platelet-activating factor in rats. 1997 Dig. Dis. Sci. pmid:9440637
Lee EK and Kehrli ME Expression of adhesion molecules on neutrophils of periparturient cows and neonatal calves. 1998 Am. J. Vet. Res. pmid:9442240
Sugimoto Y et al. Effects of apafant on PAF-induced downregulation of beta-adrenoceptors in guinea pigs. 1997 Methods Find Exp Clin Pharmacol pmid:9442478
Murohara T et al. Vascular endothelial growth factor/vascular permeability factor enhances vascular permeability via nitric oxide and prostacyclin. 1998 Jan 6-13 Circulation pmid:9443437
LeVan TD et al. Platelet-activating factor induction of activator protein-1 signaling in bronchial epithelial cells. 1998 Mol. Pharmacol. pmid:9443941
Nilsson J et al. Lipoprotein-like phospholipid particles inhibit the smooth muscle cell cytotoxicity of lysophosphatidylcholine and platelet-activating factor. 1998 Arterioscler. Thromb. Vasc. Biol. pmid:9445250
Dent G et al. Protein kinase C inhibition enhances platelet-activating factor-induced eicosanoid production in human eosinophils. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9448055
Moore RM et al. Effect of platelet-activating factor antagonist L-691,880 on low-flow ischemia-reperfusion injury of the large colon in horses. 1998 Jan-Feb Vet Surg pmid:9449176
van der Bruggen T et al. Cytokine-induced protein tyrosine phosphorylation is essential for cytokine priming of human eosinophils. 1998 J. Allergy Clin. Immunol. pmid:9449508
Shah BH et al. Role of phosphatidylinositol 3-kinase in human platelet aggregation. 1997 Biochem. Soc. Trans. pmid:9450028
Akagi M et al. Inhibitor effect of apafant on bronchopulmonary responses to platelet activating factor and to antigen in rats. 1997 Arzneimittelforschung pmid:9450165
Hirashima Y et al. Platelet-activating factor and edema surrounding meningiomas. 1998 J. Neurosurg. pmid:9452240
Oancea E et al. Green fluorescent protein (GFP)-tagged cysteine-rich domains from protein kinase C as fluorescent indicators for diacylglycerol signaling in living cells. 1998 J. Cell Biol. pmid:9456311
Suzuki M et al. Continuous binding of the PAF molecule to its receptor is necessary for the long-term aggregation of platelets. 1998 Am. J. Physiol. pmid:9458712
Cao Y et al. Expression of plasma platelet-activating factor acetylhydrolase is transcriptionally regulated by mediators of inflammation. 1998 J. Biol. Chem. pmid:9461591
Kulikov VI and Muzya GI Ether lipids and platelet-activating factor: evolution and cellular function. 1997 Biochemistry Mosc. pmid:9461631
Sibelius U et al. Wegener's granulomatosis: anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response. 1998 J. Exp. Med. pmid:9463400
Winkler JD et al. Beta-lactams SB 212047 and SB 216754 are irreversible, time-dependent inhibitors of coenzyme A-independent transacylase. 1998 Mol. Pharmacol. pmid:9463491
Kruse-Elliott KT et al. Role of lipid-derived mediators in tumor necrosis factor-induced endothelin-1 release in vivo. 1998 Shock pmid:9466472
Wang HG et al. The role of endogenous nitric oxide in the sympathetic and hemodynamic response to platelet activating factor-induced hypotension in anesthetized dogs. 1998 Shock pmid:9466475
Fadok VA et al. Macrophages that have ingested apoptotic cells in vitro inhibit proinflammatory cytokine production through autocrine/paracrine mechanisms involving TGF-beta, PGE2, and PAF. 1998 J. Clin. Invest. pmid:9466984
Singh N et al. Possible mechanism of alprazolam-induced amnesia in mice. 1998 Pharmacology pmid:9467187
Golubeva TS et al. [Determination of the nucleosomal fragmentation of DNA of ACL cells during their incubation with human platelets]. 1997 Biull Eksp Biol Med pmid:9471253
Chupin VV et al. On the synthesis of platelet-activating factor via acetylation of 1-alkyl-sn-glycero-3-phosphocholine. Formation of structural isomer of PAF in the presence of bases. 1996 Chem. Phys. Lipids pmid:9471401
Thakur A et al. The proinflammatory cytokines and arachidonic acid metabolites in human overnight tears: homeostatic mechanisms. 1998 J. Clin. Immunol. pmid:9475355
Miotla JM et al. Platelet-activating factor plays a pivotal role in the induction of experimental lung injury. 1998 Am. J. Respir. Cell Mol. Biol. pmid:9476906
Jung KY et al. Platelet activating factor antagonist activity of ginsenosides. 1998 Biol. Pharm. Bull. pmid:9477174
Renis M et al. Glutamine synthetase activity and HSP70 levels in cultured rat astrocytes: effect of 1-octadecyl-2-methyl-rac-glycero-3-phosphocholine. 1998 Brain Res. pmid:9479063
Péterfy M et al. Cloning and characterization of cDNAs and the gene encoding the mouse platelet-activating factor acetylhydrolase Ib alpha subunit/lissencephaly-1 protein. 1998 Genomics pmid:9479492
Antonopoulou S et al. Identification of a new endogenous platelet-activating factor-like molecule in gingival crevicular fluid. 1998 Biochem. J. pmid:9480892
Mason GR et al. Appropriate background correction for DTPA aerosol clearance. 1998 J. Appl. Physiol. pmid:9480975
Erickson KL Dietary fat, breast cancer, and nonspecific immunity. 1998 Nutr. Rev. pmid:9481130
Abu-Zidan FM Unexpected action of platelet activating factor antagonism after fluid resuscitation from traumatic shock. 1998 Surgery pmid:9481416
Jocks T et al. Platelet-activating factor mediates monocyte chemoattractant protein-1 expression in glomerular immune injury. 1998 Nephrol. Dial. Transplant. pmid:9481713
Wise H Activation of the prostaglandin EP4-receptor subtype is highly coupled to inhibition of N-formyl-methionyl-leucyl-phenylalanine-stimulated rat neutrophil aggregation. 1998 Prostaglandins Leukot. Essent. Fatty Acids pmid:9482170
Ezeamuzie CI and Al-Hage M Effects of some anti-asthma drugs on human eosinophil superoxide anions release and degranulation. 1998 Int. Arch. Allergy Immunol. pmid:9482706
Yamawaki I et al. Inhaled cromoglycate reduces airway neurogenic inflammation via tachykinin antagonism. 1997 Res. Commun. Mol. Pathol. Pharmacol. pmid:9485521
Borman RA et al. Investigation of the effects of platelet-activating factor (PAF) on ion transport and prostaglandin synthesis in human colonic mucosa in vitro. 1998 Br. J. Pharmacol. pmid:9489610
Shi LC et al. Involvement of platelet-activating factor in cell death induced under ischemia/postischemia-like conditions in an immortalized hippocampal cell line. 1998 J. Neurochem. pmid:9489723
Matusiewicz R and Rotkiewicz-Piorun A Inflammatory cells in skin immunological infiltrations. 1997 Nov-Dec J Investig Allergol Clin Immunol pmid:9491202
Yang HO and Han BH Pinusolidic acid: a platelet-activating factor inhibitor from Biota orientalis. 1998 Planta Med. pmid:9491770
Rice SQ et al. Expression, purification and characterization of a human serine-dependent phospholipase A2 with high specificity for oxidized phospholipids and platelet activating factor. 1998 Biochem. J. pmid:9494101
Moritani C et al. Activation of platelets in bronchial asthma. 1998 Chest pmid:9498966
Pettit EJ and Hallett MB Ca2+ signalling delays in neutrophils: effects of prior exposure to platelet activating factor or formyl-met-leu-phe. 1998 Cell. Signal. pmid:9502117
Kimura K et al. Modulation of platelet activating factor-induced glycogenolysis in the perfused rat liver after administration of endotoxin in vivo. 1998 J. Biochem. pmid:9504421
Roy Baker R and Chang H Substrate specificities of neuronal nuclear acetyltransferases involved in the synthesis of platelet-activating factor: differences in the use of 1-alkyl and 1-acyl lysophospholipid acceptors. 1998 Biochim. Biophys. Acta pmid:9507140
Wilson PG et al. Acute pancreatitis as a model of sepsis. 1998 J. Antimicrob. Chemother. pmid:9511087
Fink MP Therapeutic options directed against platelet activating factor, eicosanoids and bradykinin in sepsis. 1998 J. Antimicrob. Chemother. pmid:9511090
Qayumi KA et al. A new platelet-activating factor antagonist (CV-6209) in preservation of heart and lung for transplantation. 1997 Cardiovasc Drugs Ther pmid:9512873
Webber SE et al. PAF-induced secretory hyperresponsiveness in the ferret trachea to bradykinin and its pharmacological inhibition. 1997 Pulm Pharmacol Ther pmid:9514626
Balsa D et al. Effects of a new platelet-activating factor antagonist, UR-12670, on several endotoxic shock markers in rats. 1997 Drugs Exp Clin Res pmid:9515229
Chung KF Platelet activating factor revisited. 1997 Thorax pmid:9516891
Shindo K et al. Enhancement of leukotriene B4 release in stimulated asthmatic neutrophils by platelet activating factor. 1997 Thorax pmid:9516893
Cannon TR et al. Mechanisms of acute vasodilator response to bacterial lipopolysaccharide in the rat coronary microcirculation. 1998 Br. J. Pharmacol. pmid:9517382
Tsuji H et al. The presence of platelet-activating factor-acetylhydrolase in human middle ear effusions. 1998 Jan-Feb ORL J. Otorhinolaryngol. Relat. Spec. pmid:9519378
Lukiw WJ et al. Budesonide epimer R or dexamethasone selectively inhibit platelet-activating factor-induced or interleukin 1beta-induced DNA binding activity of cis-acting transcription factors and cyclooxygenase-2 gene expression in human epidermal keratinocytes. 1998 Proc. Natl. Acad. Sci. U.S.A. pmid:9520467
Evangelista S et al. Antihistaminic and antiallergic properties of dextro-mequitamium iodide in upper and lower guinea pig airways: comparison with azelastine. 1998 Gen. Pharmacol. pmid:9522168
Yoshikawa T et al. alpha-Tocopherol protects against expression of adhesion molecules on neutrophils and endothelial cells. 1998 Biofactors pmid:9523024
Lopes-Martins RA et al. The acute increases in vasomotor tone and blood pressure induced by carotid artery occlusion are modulated by platelet-activating factor (PAF) independently of nitric oxide release. 1997 J Lipid Mediat Cell Signal pmid:9524924
Oh-hashi K et al. Possible mechanisms for the differential effects of high linoleate safflower oil and high alpha-linolenate perilla oil diets on platelet-activating factor production by rat polymorphonuclear leukocytes. 1997 J Lipid Mediat Cell Signal pmid:9524928
Diven WF et al. Expression of acute otitis media after receptor blockade of platelet activating factor, thromboxane, and leukotrienes in the chinchilla. 1998 Ann. Otol. Rhinol. Laryngol. pmid:9525240
Kulikov VI and Muzya GI The bioregulatory role of platelet-activating factor in intracellular processes and cell-cell interactions. 1998 Biochemistry Mosc. pmid:9526094
Mabilat-Pragnon C et al. Urokinase localization and activity in isolated eosinophils. 1997 Thromb. Res. pmid:9526961
Harris AG et al. Mechanisms of cell injury in rat mesentery and cremaster muscle. 1998 Am. J. Physiol. pmid:9530215
Ostrovsky L et al. A juxtacrine mechanism for neutrophil adhesion on platelets involves platelet-activating factor and a selectin-dependent activation process. 1998 Blood pmid:9531616
Michibayashi T Different types of vasocontractile responses to noradrenaline in the presence of platelets with platelet activating factor. 1997 J Smooth Muscle Res pmid:9533823
Yamada T et al. Effects of inhaled nitric oxide on platelet-activating factor-induced pulmonary hypertension in dogs. 1998 Acta Anaesthesiol Scand pmid:9542566
Ishii I et al. Agonist-induced sequestration, recycling, and resensitization of platelet-activating factor receptor. Role of cytoplasmic tail phosphorylation in each process. 1998 J. Biol. Chem. pmid:9545329
Bonsignore L et al. One-step synthesis and pharmacological activity of new (N-substituted)amino-spiroalkan-dione derivatives. 1997 Farmaco pmid:9550091
Sperber K et al. Mucin secretion in inflammatory bowel disease: comparison of a macrophage-derived mucin secretagogue (MMS-68) to conventional secretagogues. 1998 Inflamm. Bowel Dis. pmid:9552223